These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8167093)

  • 1. Testing of a chemosensitivity screening method on sensitive and resistant breast tumoral epithelial cell lines.
    Colomb E; Martin PM
    Anal Cell Pathol; 1994 Feb; 6(2):105-16. PubMed ID: 8167093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear texture parameters as discriminant factors in cell cycle and drug sensitivity studies.
    Colomb E; Dussert C; Martin PM
    Cytometry; 1991; 12(1):15-25. PubMed ID: 1999121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S phase, an evolutionary chromatin condensation state from G1 to G2, in a breast epithelial cell line.
    Colomb E; Martin PM
    Anal Cell Pathol; 1992 Sep; 4(5):369-79. PubMed ID: 1445795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescence image analysis of the MCF-7 cycle related changes in chromatin texture. Differences between AT- and GC-rich chromatin.
    Santisteban MS; Brugal G
    Anal Cell Pathol; 1995 Jul; 9(1):13-28. PubMed ID: 7577751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TCA-100 tumour chemosensitivity assay: differences in sensitivity between cultured tumour cell lines and clinical studies.
    Andreotti PE; Linder D; Hartmann DM; Cree IA; Pazzagli M; Bruckner HW
    J Biolumin Chemilumin; 1994; 9(6):373-8. PubMed ID: 7879653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticancer chemosensitivity profiles of human breast cancer cells assessed by in vitro DNA synthesis inhibition assay.
    Nio Y; Tamura K; Kan N; Inamoto T; Ohgaki K; Kodama H
    Anticancer Res; 2000; 20(2B):1237-44. PubMed ID: 10810427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new assay to evaluate cell growth and drug sensitivity in culture using a cell image processor.
    Kiss R; de Launoit Y; Gras S; Thibaut S; Atassi G
    Anticancer Res; 1988; 8(4):765-74. PubMed ID: 3178165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomerase assay as a possible predictor of the response to anticancer chemotherapy.
    Terashima M; Takiyama I; Uesugi N; Sasaki N; Takagane A; Hayakawa Y; Abe K; Araya M; Nishizuka S; Shimooki O; Nakaya T; Irinoda T; Yonezawa H; Oyama K; Saito K
    Anticancer Res; 2000; 20(1A):293-7. PubMed ID: 10769670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A sensitive assay for the evaluation of cytotoxicity and its pharmacologic modulation in human solid tumor-derived cell lines exposed to cancer-therapeutic agents.
    Mirzayans R; Andrais B; Scott A; Tessier A; Murray D
    J Pharm Pharm Sci; 2007; 10(2):298s-311s. PubMed ID: 17718933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoresistant cell lines: morphonuclear characteristics and chemosensitivity development during long-term culture.
    Pauwels O; Kiss R
    Anticancer Res; 1993; 13(5A):1593-9. PubMed ID: 8239539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of doxorubicin sensitivity in breast tumors based on gene expression profiles of drug-resistant cell lines correlates with patient survival.
    Györffy B; Serra V; Jürchott K; Abdul-Ghani R; Garber M; Stein U; Petersen I; Lage H; Dietel M; Schäfer R
    Oncogene; 2005 Nov; 24(51):7542-51. PubMed ID: 16044152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin fails to interfere with the antiproliferative and cytotoxic effects of antitumor drugs.
    Gewirtz DA; Di X; Walker TD; Sawyer ST
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2232-8. PubMed ID: 16609039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of sensitivity to doxorubicin and etoposide by transfection of MCF-7 breast cancer cells with heregulin beta-2.
    Harris LN; Yang L; Tang C; Yang D; Lupu R
    Clin Cancer Res; 1998 Apr; 4(4):1005-12. PubMed ID: 9563896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of culture conditions on the chemosensitivity of ovarian cancer cell lines.
    Fernando A; Glaysher S; Conroy M; Pekalski M; Smith J; Knight LA; Di Nicolantonio F; Cree IA
    Anticancer Drugs; 2006 Sep; 17(8):913-9. PubMed ID: 16940801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of apoptosis by flavopiridol in mitomycin-C-treated gastric and breast cancer cells.
    Schwartz GK; Farsi K; Maslak P; Kelsen DP; Spriggs D
    Clin Cancer Res; 1997 Sep; 3(9):1467-72. PubMed ID: 9815832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation of DNA repair protein Rad51 in human tumour cell lines exposed to doxorubicin.
    Koehn H; Magan N; Isaacs RJ; Stowell KM
    Anticancer Drugs; 2007 Apr; 18(4):419-25. PubMed ID: 17351394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.
    Saleh EM; El-Awady RA; Abdel Alim MA; Abdel Wahab AH
    Cell Biochem Biophys; 2009; 55(2):95-105. PubMed ID: 19593673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear targeting and nuclear retention of anthracycline-formaldehyde conjugates implicates DNA covalent bonding in the cytotoxic mechanism of anthracyclines.
    Taatjes DJ; Fenick DJ; Koch TH
    Chem Res Toxicol; 1999 Jul; 12(7):588-96. PubMed ID: 10409398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro drug sensitivity testing with agar-containing glass capillaries.
    Lathan B; Kerkhoff K; Scheithauer W; Diehl V
    Anticancer Res; 1990; 10(4):1075-8. PubMed ID: 2382979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance of formation of micronuclei in SCC VII murine cells treated with various chemotherapeutic agents].
    Jeremić B; Sibamoto J; Abe M
    Srp Arh Celok Lek; 1996; 124(7-8):169-74. PubMed ID: 9102841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.